Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential

BACKGROUND: Despite progress that has been made in the treatment of many immune-mediated inflammatory diseases (IMIDs), there remains a need for improved treatments. Randomised controlled trials (RCTs) provide the highest form of evidence on the effectiveness of a potential new treatment regimen, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayling, Michael J., Bigirumurame, Theophile, Cherlin, Svetlana, Ouma, Luke, Zheng, Haiyan, Wason, James M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252241/
https://www.ncbi.nlm.nih.gov/pubmed/34210348
http://dx.doi.org/10.1186/s41927-021-00192-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252241/
https://www.ncbi.nlm.nih.gov/pubmed/34210348
http://dx.doi.org/10.1186/s41927-021-00192-5

Ejemplares similares